PPD, Inc. (PPD) stock barely changed on Friday a 0.30% closing at $47.04 and setting the new all-time highs at $47.08.

Since the price bottomed at $45.68 last July, the stock surged by 2.98%.

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services.. The stock belongs to the Drug Manufacturers - Specialty & Generic industry in the Healthcare sector. The firm's Headquarters are in Wilmington, United States, and has 28,000 employees worldwide. Check for further information at its corporate site at http://www.ppd.com.